-
公开(公告)号:US20220280632A1
公开(公告)日:2022-09-08
申请号:US17628640
申请日:2020-07-24
申请人: Bryce CHACKERIAN , David S. PEABODY , Nikolai PETROVSKY , Lucia JELINKOVA , Fidel ZAVALA , UNM RAINFOREST INNOVATIONS , THE JOHNS HOPKINS UNIVERSITY , VAXINE PTY LTD.
IPC分类号: A61K39/12 , C07K14/005 , C12N7/00 , A61P33/06
摘要: An immunogen useful for treating malaria generally includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide that includes the peptide NPDPNANPNVDPNAN (amino acids 5-19 of SEQ ID NO:1) linked to the immunogenic carrier. The immunogen may be administered to a subject having or at risk of having malaria.
-
公开(公告)号:US20230102159A1
公开(公告)日:2023-03-30
申请号:US17953712
申请日:2022-09-27
IPC分类号: A61K39/015 , A61P33/06 , C12N15/63
摘要: An immunogen useful for treating malaria generally includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide that includes the peptide NANPNVDPNANPNVD (SEQ ID NO:2) linked to the immunogenic carrier. The immunogen may be administered to a subject having or at risk of having malaria. Alternatively, the immunogen may be administered to an individual having or at risk of having Plasmodium falciparum blood stage parasitemia. In some cases, the immunogen can be administered in combination with another therapeutic agent for treating malaria of Plasmodium falciparum blood stage parasitemia.
-